Background & Objectives: Oral Squamous Cell Carcinoma (OSCC) showed a significant risk to develop local recurrences or second primary tumours during follow-up. Recently, we developed a non-invasive assay based on oral brushing and DNA methylation analysis to early detect OSCC. In the present study using this assay, we investigated the adjacent area of surgical resection in a series of OSCC during follow-up for prog- nostic purposes. Methods: 42 consecutive OSCC patients were sampled during routine follow-up after 6 months from surgical treatment, brushing the regenera- tive mucosa covering the region that underwent the surgical OSCC exci- sion. DNA methylation level of ZAP70, GP1BB, KIF1A, ITGA4, LINC00599, MIR193, MIR296, TERT, LRRTM1, NTM, EPHX3, FLI1 and PARP15 was evaluated by quantitative Bisulfite-NGS. After calcu- lating a score by Linear-Discriminant-Analysis, the samples were dichot- omized using a predefined threshold previously developed for early di- agnosis. One-Way-ANOVA and Kaplan-Meier curves served to evaluate any significant difference between patients who experienced a second neoplastic manifestation and the group who did not. Results: 6/42 (14,3%) patients developed a second neoplastic manifesta- tion during follow-up period (mean follow-up: 14.3 months), of which 5 showed a positive methylation score. Additional 11 patients exceeded the threshold but up to date they have not experienced any second manifes- tation. Among the remaining 26 negatives, only one developed a recur- rence. A positive score correlated with a worse locoregional control of disease (p<0.05). Conclusion: The DNA methylation analysis of 13 genes can be a useful non-invasive method to identify surgically treated OSCC patients at risk of developing a second neoplasia.
Morandi, L., Gissi, D.B., Rossi, R., Tarsitano, A., Gabusi, A., Montebugnoli, L., et al. (2019). Prognostic impact of DNA methylation analysis in adjacent area of surgically resected oral squamous cell carcinoma during follow up. VIRCHOWS ARCHIV, 475, S25-S25.
Prognostic impact of DNA methylation analysis in adjacent area of surgically resected oral squamous cell carcinoma during follow up
Morandi, L
Writing – Review & Editing
;Gissi, DB;Rossi, R;Tarsitano, A;Gabusi, A;Montebugnoli, L;Marchetti, C;Foschini, MP
2019
Abstract
Background & Objectives: Oral Squamous Cell Carcinoma (OSCC) showed a significant risk to develop local recurrences or second primary tumours during follow-up. Recently, we developed a non-invasive assay based on oral brushing and DNA methylation analysis to early detect OSCC. In the present study using this assay, we investigated the adjacent area of surgical resection in a series of OSCC during follow-up for prog- nostic purposes. Methods: 42 consecutive OSCC patients were sampled during routine follow-up after 6 months from surgical treatment, brushing the regenera- tive mucosa covering the region that underwent the surgical OSCC exci- sion. DNA methylation level of ZAP70, GP1BB, KIF1A, ITGA4, LINC00599, MIR193, MIR296, TERT, LRRTM1, NTM, EPHX3, FLI1 and PARP15 was evaluated by quantitative Bisulfite-NGS. After calcu- lating a score by Linear-Discriminant-Analysis, the samples were dichot- omized using a predefined threshold previously developed for early di- agnosis. One-Way-ANOVA and Kaplan-Meier curves served to evaluate any significant difference between patients who experienced a second neoplastic manifestation and the group who did not. Results: 6/42 (14,3%) patients developed a second neoplastic manifesta- tion during follow-up period (mean follow-up: 14.3 months), of which 5 showed a positive methylation score. Additional 11 patients exceeded the threshold but up to date they have not experienced any second manifes- tation. Among the remaining 26 negatives, only one developed a recur- rence. A positive score correlated with a worse locoregional control of disease (p<0.05). Conclusion: The DNA methylation analysis of 13 genes can be a useful non-invasive method to identify surgically treated OSCC patients at risk of developing a second neoplasia.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.